Publication Rules

Galicia Clínica

Galicia Clínica is the official journal of the Galician Society of Internal Medicine (SOGAMI). They publish 4 issues a year, both hardcopy and on; the latter including notices sent to the corresponding Ordinary Meeting of the SOGAMI.

Publication Rules

GALICIA CLÍNICA will evaluate for publication medical works related preferably to Internal Medicine and its sub-specialities, and/or with medical problems prevalent in the Autonomous Region of Galicia. Works will be accepted for consideration in Spanish and English.

A form will be enabled on the website to facilitate submission of originals. The system will confirm the submission and will enable users to consult the status of the manuscript. Originals sent by other means will not be accepted.

The editorial board, which will from time to time seek assistance from external reviewers, will evaluate the works submitted, determining whether they are apt for publication, require corrections or are rejected for publication. Once accepted, the author will be sent print proofs for the correction of any possible typographical errors.

Works must meet the uniformity requirements regularly found in biomedical journals. These requirements may be consulted in “Uniform Requirements for Manuscripts Submitted to Biomedical Journals: Writing and Editing for Biomedical Publication, Updated April 2010”, available on Authors are highly encouraged to read the “Preparing a Manuscript for Submission to a Biomedical Journal” section especially (, and to follow its indications exactly when drafting the work to be submitted.

We recommend using the more common word processors (e.g. Microsoft Word) for both the text and the tables. Given that most pages are printed in black and white, we advise avoiding as much as possible the use of tables and figures that use colours or segments that do not have sufficient contrast to ensure identification. Figures and images must be sent in a separate file, as an image file (jpeg or similar) or as a PDF with a final print size resolution of 300 dpi.

All works must be submitted with the title in the original language and in English, and with at least 3 keywords.

The bibliography must be referenced in accordance with the ICMJE standards

Once authors have implemented the corrections suggested by the reviewer, they must send a letter of response to the reviewer; that is, they must submit the corrected manuscript, accompanied by a letter responding to each one of the reviewer’s individual comments.
The journal includes the following sections:

Normally submitted by request of the journal’s editorial board. They are a maximum of 8 pages long, with 30 lines each, with one figure or one table and 15 bibliographical references. They may be signed by a maximum of two authors.

Normally submitted by request on the journal’s editorial board. They are a maximum of 30 pages long, with 30 lines each, plus 6 figures and 6 tables, and a maximum of 50 bibliographical references. The work may be signed by a maximum of three authors.

Research work on any medical aspect. The works shall follow the traditional general structure: Title: in the original language and in English, Abstract, Keywords (which must correspond to the medical subjects headings -MESH- of the Index Medicus), Introduction, Material and methods, Results, Discussion, Bibliography. The maximum recommended length of the text is 20 pages, with 30 lines each, plus 5 figures and 5 tables, and a maximum of 30 bibliographical references. The work may be signed by a maximum of eight authors.

Brief Originals
Research works that, due to their characteristics, do not require more space. Similar structure to the originals. They are a maximum of 10 pages long, with 30 lines each, 3 figures, 3 tables and 20 bibliographical references. The work may be signed by a maximum of six authors.

Clinical Notes
Description of clinical cases of exceptional interest. They will include a brief introduction, clinical case and the corresponding discussion. They are a maximum of 6 pages long, with two figures and two tables and 15 bibliographical references. The work may be signed by a maximum of four authors.

Letters to the Editor
Comments, opinions or observations on the different works published previously in the journal. They are a maximum of 4 pages long, with 30 lines each, with one figure or one table and 10 bibliographical references allowed. They may be signed by a maximum of two authors.

Clinical Questions
This section will provide specific, succinct answers to specific questions that have either led to a controversy or have questioned deeply-held beliefs in daily practice. They are a maximum of 6 pages long, with 30 lines each, two figures and two tables and 15 bibliographical references. They may be signed by a maximum of two authors.

Medical Images
Curious, unusual or demonstrative images. They are accompanied by a brief text, no more than 1 page long, with 30 lines, which explains the clinical text, with a brief discussion on the importance of the image. They may be signed by a maximum of two authors.

Doctoral Thesis Abstracts
Written by the author, they describe the work done. They may be a maximum of 2 pages long, with 30 lines each. They must include an appendix with the details corresponding to the University, department, thesis director and date of submission.

The journal’s editorial board will consider for publication any article related to any aspect of medicine, even if not included exactly within the cases above. In this case, before submitting the work, we recommend contacting the editorial board to discuss its characteristics.

If the works submitted include images, figures, tables or texts subject to copyright, it will be the responsibility of the authors to secure the permission necessary for publication.

All opinions or statements expressed in the articles are those of the authors. Both the editorial board and the SOGAMI waive any liability in this regard.

Published works become the property of GALICIA CLÍNICA, and the authors relinquish all rights to the same.

Ethical aspects:

The authors must have carried out their research according to the principles from the Declaration of Helsinki, the standards for Good Clinical Practice, and the legislation in force.

Informed consent:
In all clinical trials, the authors must report on whether they have the appropriate authorisation from the ethics committee, as well as written informed consent (or an exemption for the need to have this issued by the ethics committee). If clinical cases are published, the authors must have the patient’s authorisation to publish the case, and it must be ensured that no information that could allow the patient to be identified is included. Photographs must not allow the patient to be identified (if the patient’s face is included, the area around the eyes must be covered with an opaque black strip), and written authorisation from the patient for publication of such photos must also be included.

Conflicts of interest:
The authors must declare all possible conflicts of interest in the form of personal or financial relationships that could bear some relation to the results from the article. If no conflicts of interest exist, the authors must state this in a section of the manuscript using the phrase “There are no conflicts of interest existing”. The funding sources for the article must be included in the acknowledgments section.

The article submitted must not have been previously published (except as a presentation at a scientific conference or as part of a doctoral thesis), and must not be subject to review by another journal at the time it is submitted.

All authors included on the article must comply with the authorship requirements described by the ICMJE (

For all research work that involves patients, informed consent must be obtained from the patients in writing for their participation in the research.

Experimentation on human subjects:
Scientific research and experimentation involving humans is a right and a duty of the scientific and biomedical communities. Scientific experimentation represents an important means of progress for our knowledge of human nature. This knowledge must be taken advantage of in order to increase the well-being, health, and quality of life of all humans.

In the case of research involving experimentation on humans, the following items must be explicitly included in an independent document, which must be attached to the article:

  • During research involving humans, the interests of science and society must never take precedence over the well-being of the subjects. The right of the subjects to protect their own integrity must always be respected. All precautions must be taken to preserve the physical and psychological integrity of the persons participating as experimental subjects.
  • Experimentation involving humans that could present risks or burdens for the subjects must only be performed when no alternative procedures of comparable efficacy exist.
  • Biomedical research on humans must comply with the commonly accepted ethical and scientific standards. It must be based on evaluation of the risks, carried out on the basis of previous experiments properly performed in the laboratory and on animals, and on the basis of reasonable knowledge of the possible consequences of the experiment. Experimentation must not be performed using a person if a method of comparable efficacy exists as an alternative to experimenting with humans.
  • Proportionality between the benefits and risks of the research. The risks or burdens produced by the experimentation on humans must not be disproportionate and must not involve a lapse of moral conscience or violation of the subject’s dignity. In the case of biomedical research, the importance of the objectives must be proportional to the risk that the subjects face by participating.
  • All biomedical research projects involving humans must be preceded by careful calculation of the predictable risks and their comparison to the benefits that the research could produce for the subject and for other individuals.
  • Concern for the interests of the persons who are research subjects must always take precedence over the interests of science and society. Research or experimentation must always be suspended if the risks are found to be greater than the calculated benefits.
  • Participation in any research or experiment must require the free and informed consent of the experimentation subject after this person has received adequate information about the nature and purpose of the experiment, the objectives, the methods, the calculated benefits, and the possible risks or burdens that could be involved. The subjects must be allowed to freely withdraw their consent at any time, without suffering any negative consequences because of this. If minors or persons with disabilities with diminished personal competency or autonomy are participating in the research, the consent must always be granted in writing by this person’s legal representative or by the person with the duty of care.
  • If the researchers are offering subjects incentives or compensation for their participation in the research or experiment, whether economic or of any other type, in no case may the amount offered be so high that it could not be reasonably rejected by the subject.
  • The researchers have the duty to guarantee the right to privacy of the subjects. For work involving a team, each researcher is responsible for maintaining secrecy for the totality of the project. All participants in a research project with human subjects must maintain the strictest confidentiality, so that the personal and family privacy of the participating subjects is not violated.
  • During all scientific research or experiments, the experimental subjects or participants must be treated with the highest degree of respect for their dignity, beliefs, privacy, and decency, especially including protection for the most vulnerable persons.
  • In all scientific experimentation or research, the identity of the researcher or researchers responsible for the project must be clearly defined, as well as the identities of all other research team members who may be acting as collaborators.
  • Liability derived from the research must always fall upon the researcher, never upon the research subject, even though the subject has given his or her informed consent. Approval of experimental protocols by an ethics committee does not release the researchers from their own direct liability.

Animal experimentation:
If any part of the research work has been performed on animals, the work must also comply with the requirements issued by the corresponding clinical research committee, and authorisation must also be received from this committee.
Galicia Clínica will only evaluate work that includes animal experimentation when the following objectives are being pursued:

  1. Prevention of illnesses or other health alterations or anomalies or their effects, as well as diagnosis and treatment of these in humans, in vertebrate or invertebrate animals, or in plants; development and manufacturing of pharmaceutical and food products and other substances or products, as well as performance of testing to verify their quality, efficacy, and safety.
  2. Evaluation, detection, standardisation, or modification of the physiological conditions of humans, vertebrate or invertebrate animals, or plants.
  3. Protection of the natural environment for the benefit of human health or well-being, or that of vertebrate or invertebrate animals or plants.
  4. Scientific research.
  5. Education and training.
  6. Medical-legal research.